Modelling Fibrotic Lung Diseases

SCIREQ hosted an informative panel discussion event during the 2022 American Thoracic Society (ATS) conference on the theme of pre-clinical pulmonary fibrosis models.

The panelists: Dr. Claude Le Saux (University of California, San Francisco, CA, USA), Dr. Elizabeth Redente (National Jewish Health, Denver, CO, USA) and Dr. Annette Robichaud (SCIREQ Inc., Montreal, QC, Canada) kindly shared information about their work and experiences of modelling fibrotic lung disease in a panel discussion format, with a particular focus on the bleomycin model.

This document summarizes some of the key points that were explored during the event, and provides references to related emka & SCIREQ documents, as additional resources

Please fill out the form to access the document.


Note: Institutional firewalls may prevent downloading directly from the website. Please contact if there are any difficulties accessing the documentation

Download Summary